Early-stage non-squamous non-small cell lung cancer (NSCLC)

Clinical trials for Early-stage non-squamous non-small cell lung cancer (NSCLC) explained in plain language.

Never miss a new study

Get alerted when new Early-stage non-squamous non-small cell lung cancer (NSCLC) trials appear

Sign up with your email to follow new studies for Early-stage non-squamous non-small cell lung cancer (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Cheaper keytruda clone tested for early lung cancer

Disease control Ongoing

This study tests whether ABP 234, a biosimilar to the cancer drug Keytruda, works the same in people with early-stage non-squamous lung cancer after surgery and chemotherapy. About 163 adults will receive either ABP 234 or Keytruda to compare how the drug behaves in the body. The…

Matched conditions: EARLY-STAGE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

Phase 3 • Sponsor: Amgen • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

Early-stage non-squamous non-small cell lung cancer (NSCLC)

Get alerted when new Early-stage non-squamous non-small cell lung cancer (NSCLC) trials appear

Cheaper keytruda clone tested for early lung cancer